We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$78.5M
Cap. Flow
+$48.3M
Cap. Flow %
8.16%
Top 10 Hldgs %
62.58%
Holding
88
New
16
Increased
4
Reduced
1
Closed
7

Top Buys

1
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$13.8M
2
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.66M
3
FLNA
Filana Therapeutics
FLNA
+$8.48M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$5.53M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$4.6M

Top Sells

1
TGTX icon
TG Therapeutics
TGTX
+$3.9M
2
IDN icon
Intellicheck
IDN
+$2.99M
3
EOSEW
Eos Energy Enterprises Warrant
EOSEW
+$2.08M
4
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.53M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$1.13M

Sector Composition

1 Healthcare 23.53%
2 Industrials 13.57%
3 Consumer Discretionary 12.6%
4 Materials 9.11%
5 Financials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$912B
$4.57M 0.77%
30,000
– –
LSXMA
27
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$4.57M 0.77%
141,002
– –
NGL icon
28
NGL Energy Partners
NGL
$1.91B
$4.31M 0.73%
2,112,695
– –
CNST
29
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$4.27M 0.72%
+182,500
New +$5.53M
GBT
30
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.08M 0.69%
+100,000
New +$4.6M
ADRA.U
31
DELISTED
Adara Acquisition Corp Units
ADRA.U
$3.97M 0.67%
+400,000
New +$4.05M
AMP icon
32
Ameriprise Financial
AMP
$47.9B
$3.72M 0.63%
15,993
– –
AXP icon
33
American Express
AXP
$247B
$3.54M 0.6%
25,000
– –
CRIS icon
34
Curis
CRIS
$9.71M
$3.53M 0.6%
780
+63
+9% +$263K
DISH
35
DELISTED
DISH Network Corp.
DISH
$2.81M 0.47%
77,500
– –
EPD icon
36
Enterprise Products Partners
EPD
$82.2B
$2.78M 0.47%
126,301
– –
SONO icon
37
Sonos
SONO
$1.7B
$2.44M 0.41%
65,000
– –
BRPMU
38
DELISTED
B. Riley Principal 150 Merger Corp. Unit
BRPMU
$2.25M 0.38%
+225,000
New +$2.29M
IHC
39
DELISTED
Independence Holding Company
IHC
$2.18M 0.37%
54,711
– –
LBTYK icon
40
Liberty Global Class C
LBTYK
$3.52B
$1.78M 0.3%
69,618
– –
RIBT
41
DELISTED
RiceBran Technologies
RIBT
$1.69M 0.28%
170,333
– –
WGS icon
42
GeneDx Holdings
WGS
$1.83B
$1.49M 0.25%
+3,030
New +$1.58M
HCAR
43
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$1.45M 0.25%
+150,000
New +$1.5M
PYPL icon
44
PayPal
PYPL
$50B
$1.21M 0.21%
5,000
– –
VATE icon
45
INNOVATE Corp
VATE
$128M
$1.08M 0.18%
27,480
– –
QUMU
46
DELISTED
Qumu Corp.
QUMU
$978K 0.17%
+144,726
New +$1.2M
CUE icon
47
Cue Biopharma
CUE
$117M
$915K 0.15%
2,500
– –
CMIIU
48
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$897K 0.15%
+70,100
New +$880K
YEXT icon
49
Yext
YEXT
$546M
$869K 0.15%
+60,000
New +$1M
INFI
50
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$808K 0.14%
250,000
– –
1
2
3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q1 2021 Portfolio in Review

As of Q1 2021, Bleichroeder LP held 88 positions worth $592M, up 15% from $514M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP deployed $48.3M of net new capital in Q1 2021, opening 16 new positions and adding to 4 existing holdings. Its largest new stake was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Intellicheck, an estimated $2.99M trimmed.

  • Bleichroeder LP's largest Q1 2021 buy was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.
  • Bleichroeder LP added most to Filana Therapeutics in Q1 2021, an estimated $8.48M increase.
  • Bleichroeder LP's biggest Q1 2021 reduction was Intellicheck, cutting an estimated $2.99M.
  • Bleichroeder LP fully exited TG Therapeutics in Q1 2021, selling an estimated $3.9M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $592M portfolio in Q1 2021.
  • Bleichroeder LP opened 16 new positions and closed 7 in Q1 2021.
  • Bleichroeder LP's portfolio value rose 15% quarter-over-quarter to $592M.

Based on Bleichroeder LP's 13F filing for Q1 2021, filed 17 May 2021.